MétaCan
Menu
Back to cohort
Record W1503303110

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.

2009· review· en· W1503303110 on OpenAlexaff
Jorge Martínez-Cajas, Nitika Pant Pai, Marina B. Klein, Mark A. Wainberg

Bibliographic record

VenuePubMed · 2009
Typereview
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsMcGill UniversityJewish General Hospital
Fundersnot available
KeywordsReverse transcriptaseAbacavirBiologyProteaseAtazanavirDrug resistanceVirologyGenotypeProtease inhibitor (pharmacology)GeneticsLentivirusGenetic diversityHuman immunodeficiency virus (HIV)Viral loadViral diseaseMedicinePolymerase chain reactionAntiretroviral therapyGeneEnzymePopulation
DOInot available

Abstract

fetched live from OpenAlex

The genetic diversity of HIV-1 has required its classification into types and subtypes. There is controversy as to how and to what extent genetic diversity may affect the emergence of antiretroviral drug resistance in HIV-1 subtypes other than B. To better understand the impact of genetic diversity (represented by different HIV-1 subtypes) on resistance to reverse transcriptase and protease inhibitor drugs, a systematic review was conducted on virologic and biochemical evidence obtained from work with non-B HIV-1 subtypes. We searched 11 databases and retrieved 3,486 citations on all aspects of non-B subtype-related resistance research. Twenty-seven studies with virologic and/or biochemical data met the eligibility criteria for our systematic review. Nineteen studies were found that reported phenotypes in non-B subtypes (304 from naive isolates and 242 from drug-exposed isolates) and 11 studies that used molecular biology techniques to study non-B resistance to antiretroviral drugs. Compared to the NL4-3 laboratory strain, lower baseline susceptibilities of recombinant A/G subtype virus to protease inhibitors were observed and a substantial proportion of subtype C isolates displayed higher IC50 at baseline for atazanavir. Some A/G isolates were found to have reduced susceptibility to abacavir. Mutations not typical of B subtypes include the reverse transcriptase mutation V106M and the protease mutations M89I/V and N83T. Virologic and biochemical data suggest that K65R is more likely to emerge in subtype C HIV-1. There is evidence to suggest differential effects of other mutations according to subtype, e.g. the protease inhibitor mutations I93L and M89I/V. Importantly, the most widely used commercial phenotyping systems do not take into account gag variations among natural isolates, which could limit the accuracy of measured susceptibility. Enzymatic and virologic data support the concept that naturally occurring polymorphisms in different non-B subtypes can affect the susceptibility of HIV-1 to different antiretroviral drugs, the magnitude of resistance conferred by major mutations, and the propensity to acquire some resistance mutations. Tools may need to be optimized to accurately measure drug susceptibility of non-B subtypes, especially for protease inhibitors.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.025
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.020
Threshold uncertainty score0.039

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0070.025
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0060.005
Bibliometrics0.0200.024
Science and technology studies0.0010.001
Scholarly communication0.0030.003
Open science0.0010.002
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.254
Teacher spread0.231 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations82
Published2009
Admission routes1
Has abstractyes

Explore more

Same venuePubMedSame topicHIV/AIDS drug development and treatmentFrench-language works237,207